U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07341152) titled 'A Study Comparing LTG-001 SDD Formulation To LTG-001 Crystalline Immediate Release Tablets In Healthy Participants' on Dec. 02, 2025.
Brief Summary: This is a single-center, open-label, part-randomized, crossover study in 14 healthy participants to assess the PK and safety profile of an SDD formulation of LTG-001 and two crystalline LTG-001 Instant Release tablet formulations, one of which will also be assessed at a differing dose level.
Study Start Date: Oct. 06, 2025
Study Type: INTERVENTIONAL
Condition:
Pain Management
Intervention:
DRUG: LTG-001 SDD
LTG-001
DRUG: LTG-001 Formulation A Prototype 1
LTG-001
DRUG: LTG-001 ...